4//SEC Filing
LEE ANN L. 4
Accession 0001894562-24-000022
CIK 0001894562other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:10 PM ET
Size
5.5 KB
Accession
0001894562-24-000022
Insider Transaction Report
Form 4
LEE ANN L.
Chief Technical Officer
Transactions
- Award
Stock Option (right to buy)
2024-05-17+80,416→ 160,832 totalExercise: $3.67Exp: 2031-10-27→ Common Stock (80,416 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on October 27, 2021, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 17, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 80,416 shares.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001723629
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:10 PM ET
- Size
- 5.5 KB